One particularly appealing dividend stock right now is Bristol Myers Squibb ( BMY 0.10%). It yields 5.4%, which is an ...
Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Stocks for a Dividend Stock Portfolio. Bristol-Myers Squibb Company (NYSE:BMY) is a pharmaceutical company focused on developing ...
Bristol Myers Squibb has struggled over the past few years due to patent cliffs. And to make matters worse, it will soon face ...
Bristol Myers Squibb Co. (Symbol: BMY) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a ...
If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to ...
Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $17.02B worth of stock held by ETFs, and above-average ''DividendRank'' ...
Bayer reported positive Phase 3 results for its FXIa inhibitor asundexian, hitting key efficacy and safety targets ...
Bristol-Myers Squibb is attractively valued, offers a 5%+ dividend yield, and benefits from a strong oncology pipeline after its BioNTech deal. The $11B BioNTech partnership gives BMY access to BNT327 ...
Bristol Myers Squibb is a deep value opportunity, trading at a forward PE of 7x and offering a 5.5% dividend yield. BMY's next-gen portfolio drives double-digit growth, with blockbuster drugs like ...
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company.
Fintel reports that on December 4, 2025, Scotiabank maintained coverage of Bristol-Myers Squibb (NYSE:BMY) with a Sector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results